リコンビナント
RabMAb

Anti-Androgen Receptor 抗体 [ER179(2)] (ab108341)

ab108341 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab108341 は 9 報の論文で使用されています。

  • Tong D  et al. The HIF/PHF8/AR axis promotes prostate cancer progression. Oncogenesis 5:e283 (2016). Human . PubMed: 27991916
  • Siu MK  et al. KLF4 functions as an activator of the androgen receptor through reciprocal feedback. Oncogenesis 5:e282 (2016). WB, IHC-P ; Human . PubMed: 27991915
  • Pinto F  et al. Brachyury as a potential modulator of androgen receptor activity and a key player in therapy resistance in prostate cancer. Oncotarget 7:28891-902 (2016). WB . PubMed: 27049720
  • Urbinati G  et al. Knocking Down TMPRSS2-ERG Fusion Oncogene by siRNA Could be an Alternative Treatment to Flutamide. Mol Ther Nucleic Acids 5:e301 (2016). PubMed: 27023109
  • Liu YN  et al. Loss of Androgen-Regulated MicroRNA 1 Activates SRC and Promotes Prostate Cancer Bone Metastasis. Mol Cell Biol 35:1940-51 (2015). ChIP ; Human . PubMed: 25802280
  • Yin J  et al. AR-regulated TWEAK-FN14 pathway promotes prostate cancer bone metastasis. Cancer Res 74:4306-17 (2014). ChIP ; Human . PubMed: 24970477
  • Chen S  et al. Regulation of the transcriptional activation of the androgen receptor by the UXT-binding protein VHL. Biochem J 456:55-66 (2013). PubMed: 23961993
  • Chen Y  et al. ETS factors reprogram the androgen receptor cistrome and prime prostate tumorigenesis in response to PTEN loss. Nat Med 19:1023-9 (2013). WB, IHC-P, ChIP ; Mouse . PubMed: 23817021
  • Kuhn E  et al. Ovarian Brenner tumour: a morphologic and immunohistochemical analysis suggesting an origin from fallopian tube epithelium. Eur J Cancer 49:3839-49 (2013). PubMed: 24012099

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

登録